Potentiation of local anesthetic activity of neosaxitoxin with bupivacaine or epinephrine: Development of a long-acting pain blocker

Neurotoxicity Research

Volumn 16, Issue 4, 2009, Pages 408-415

  Rodriguez Navarro, Alberto J ^a,b   Lagos, Marcelo ^a   Figueroa, Cristian ^a   Garcia, Carlos ^a   Recabal, Pedro ^a   Silva, Pamela ^a   Iglesias, Veronica ^a   Lagos, Nestor ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSIDAD ALBERTO HURTADO   (Chile)

Author keywords

Clinical trial; Local anesthetic; Long acting pain blocker; Neosaxitoxin

Indexed keywords

ADRENALIN; BUPIVACAINE; NEOSAXITOXIN; DRUG DERIVATIVE; LOCAL ANESTHETIC AGENT; SAXITOXIN;

ADULT; ANESTHESIA MECHANISM; ARTICLE; CLINICAL TRIAL; COLD SENSATION; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG INTOXICATION; DRUG POTENTIATION; HEAT SENSATION; HEMATOMA; HUMAN; HUMAN EXPERIMENT; INJECTION SITE PAIN; MALE; MONOTHERAPY; MOTOR DYSFUNCTION; MUSCLE DISEASE; NORMAL HUMAN; PAIN ASSESSMENT; PERCEPTIVE THRESHOLD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSORY EVALUATION; TOUCH; ADOLESCENT; ANALYSIS OF VARIANCE; DRUG COMBINATION; DRUG EFFECT; HYPERALGESIA; PAIN THRESHOLD; STIMULATION; TIME;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ANESTHETICS, LOCAL; BUPIVACAINE; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; DRUG SYNERGISM; EPINEPHRINE; HUMANS; HYPERALGESIA; MALE; PAIN THRESHOLD; PHYSICAL STIMULATION; SAXITOXIN; SENSORY THRESHOLDS; TIME FACTORS; YOUNG ADULT;

EID: 74949112485     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12640-009-9092-3     Document Type: Article

References (50)

1. Adams HJ, Blair MR, Takman BH (1976) The local anesthetic activity of tetrodotoxin alone and in combination with vasoconstrictors and local anesthetics. Anesth Analg 55:568-573
2. Almeida TF, Roizenblatt S, Tufik S (2004) Afferent pain pathways: a neuroanatomical review. Brain Res 1000:40-56
3. Andrinolo D, Iglesias V, García C, Lagos N (2002) Toxicokinetics and toxicodynamics of gonyautoxins after an oral toxin dose in cats. Toxicon 40:699-709
4. Ballantyne JC (2007) Opioid analgesia: perspectives on right use and utility. Pain Physician 10:479-491
5. Bernards CM, Kopacz DJ (1999) Effect of epinephrine on lidocaine clearance in vivo: a microdialysis study in humans. Anesthesiology 91:962-968
6. Bisgaard T (2006) Analgesic treatment after laparoscopic cholecystectomy: a critical assessment of the evidence. Anesthesiology 104: 835-846
7. Brennan F, Carr DB, Cousins M (2007a) Pain management: a fundamental human right. Anesth Analg 105:205-221
8. Brennan F, Carr DB, Cousins M (2007b) The role of opioids in pain management. Anesth Analg 105:1865-1866
9. Brown DL, Ransom DM, Hall JA, Leicht CH, Schroeder DR, Offord KP (1995) Regional anesthesia and local anesthetic-induced systemic toxicity: seizure frequency and accompanying cardiovascular changes. Anesth Analg 81:321-328
10. Carr DB, Goudas LC (1999) Acute pain. Lancet 353:2051-2058
11. Catterall WA (2000) From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. Neuron 26:13-25
12. CIOMS/WHO (2002) International ethical guidelines for biomedical research involving human subjects. CIOMS, Geneva
13. Cohen MJ, Schecter WP (2005) Perioperative pain control: a strategy for management. Surg Clin North Am 85:1243-1257
14. Covino BG (1986) Pharmacology of local anesthetic agents. Br J Anaesth 58:701-716
15. Evans MH (1968) Topical application of saxitoxin and tetrodotoxin to peripheral nerves and spinal roots in cat. Toxicon 5:289-294
16. Förster JG, Rosenberg PH (2003) Clinically useful adjuvants in regional anaesthesia. Curr Opin Anaesthesiol 16:477-486
17. Fukuda K, Nakajima T, Viswanathan PC, Balser JR (2005) Compound-specific Na? channel pore conformational changes induced by local anaesthetics. J Physiol 564(1):21-31
18. García C, Lagos M, Truan D, Lattes K, Ve'jar O, Chamorro B, Iglesias V, Andrinolo D, Lagos N (2005) Human intoxication with paralytic shellfish toxins: clinical parameters and toxin analysis in plasma and urine. Biol Res 38:197-205
19. Garrido R (2005) New toxin treatment for anal fissures. Nat Clin Pract Gastroenterol Hepatol 2:126-127
20. Garrido R, Lagos N, Lattes K, Azolas CG, Bocic G, Cuneo A, Chiong H, Jensen C, Henríquez AI, Fernández C (2004) The gonyautoxin 2/3 epimers reduces anal tone when injected in the anal sphincter of healthy adults. Biol Res 37:395-403
21. Garrido R, Lagos N, Lattes K, Abedrapo M, Bocic G, Cuneo A, Chiong H, Jensen C, Azolas R, Henriquez A, Garcia C (2005) Gonyautoxin: new treatment for healing acute and chronic anal fissures. Dis Colon Rectum 48:335-340
22. Grant SA (2002) The Holy Grail: long-acting local anaesthetics and liposomes. Best Pract Res Clin Anaesthesiol 16:345-352
23. Grant GJ, Barenholz Y, Bolotin EM, Bansinath M, Turndorf H, Piskoun B, Davidson EM (2004) A novel liposomal bupivacaine formulation to produce ultralong-acting analgesia. Anesthesiology 101:133-137
24. Gupta A (2005) Local anaesthesia for pain relief after laparoscopic cholecystectomy-a systematic review. Best Pract Res Clin Anaesthesiol 19:275-292
25. Hutchison RW (2007) Challenges in acute post-operative pain management. Am J Health Syst Pharm 64:S2-S5
26. Isbister GK, Kiernan MC (2005) Neurotoxic marine poisoning. Lancet Neurol 4:219-228
27. Kao CY (1972) Pharmacology of tetrodotoxin and saxitoxin. Fed Proc 31:1117-1123
28. Kehlet H, Dahl JB (1993) The value of "multimodal" or "balanced analgesiá in postoperative pain treatment. Anesth Analg 77: 1048-1056
29. Kohane DS, Yieh J, Lu NT, Langer R, Strichartz G, Berde CB (1998) A reexamination of tetrodotoxin for prolonged anesthesia. Anesthesiology 89:119-131
30. Kohane DS, Lu NT, Gökgöl-Kline AC, Shubina M, Kuang Y, Hall S, Strichartz GR, Berde CB (2000) The local anesthetic properties and toxicity of saxitonin homologues for rat sciatic nerve block in vivo. Reg Anesth Pain Med 25:52-59
31. Kohane DS, Smith SE, Louis DN, Colombo G, Ghoroghchian P, Hunfeld NG, Berde CB, Langer R (2003) Prolonged duration local anesthesia from tetrodotoxin-enhanced local anesthetic microspheres. Pain 104:415-421
32. Lagos N (1998) Microalgal bloom: a global issue with negative impact in Chile. Biol Res 31:375-386
33. Lagos N, Andrinolo D (2000) Paralytic shellfish poisoning (PSP): toxicology and kinetics. In: Botana LM (ed) Seafood and freshwater toxins: mode of action, pharmacology and physiology. Marcel Dekker, New York
34. Møiniche S, Mikkelsen S, Wetterslev J, Dahl JB (1998) A qualitative systematic review of incisional local anaesthesia for postoperative pain relief after abdominal operations. Br J Anaesth 81: 377-383
35. Møiniche S, Dahl A, Dahl JB (2000) Subcutaneous infiltration with ammonium sulphate 10% does not prolong the local anaesthetic duration of lidocaine in humans. Acta Anaesthesiol Scand 44: 878-883
36. Myers RR, Kalichman MW, Reisner LS, Powell HC (1986) Neurotoxicity of local anesthetics: altered perineural permeability, edema, and nerve fiber injury. Anesthesiology 64:29-35
37. Narahashi T (1972) Mechanism of action of tetrodotoxin and saxitoxin on excitable membranes. Fed Proc 31:1124-1132
38. Nordin P, Zetterström H, Gunnarsson U, Nilsson E (2003) Local, regional, or general anaesthesia in groin hernia repair: multicentre randomised trial. Lancet 362:853-858
39. Padera RF, Tse JY, Bellas E, Kohane DS (2006) Tetrodotoxin for prolonged local anesthesia with minimal myotoxicity. Muscle Nerve 34:747-753
40. Pedersen JL, Lillesø J, Hammer NA, Werner MU, Holte K, Lacouture PG, Kehlet H (2004) Bupivacaine in microcapsules prolongs analgesia after subcutaneous infiltration in humans: a dosefinding study. Anesth Analg 99:912-918
41. Reinikainen M, Hedman A, Pelkonen O, Ruokonen E (2003) Cardiac arrest after interscalene brachial plexus block with ropivacaine and lidocaine. Acta Anaesthesiol Scand 47:904-906
42. Rodriguez-Navarro AJ, Lagos N, Lagos M, Braghetto I, Csendes A, Hamilton J, Berger Z, Wiedmaier G, Henriquez A (2006) Intrasphincteric neosaxitoxin injection evidence of lower esophageal sphincter relaxation in achalasia. Am J Gastroenterol 101:2667-2668
43. Rodriguez-Navarro AJ, Lagos N, Lagos M, Braghetto I, Csendes A, Hamilton J, Figueroa C, Truan D, Garcia C, Rojas A, Iglesias V, Brunet L, Alvarez F (2007) Neosaxitoxin as a local anesthetic: preliminary observations from a first human trial. Anesthesiology 106:339-345
44. Sakura S, Bollen AW, Ciriales R, Drasner K (1995) Local anesthetic neurotoxicity does not result from blockade of voltage-gated sodium channels. Anesth Analg 81:338-346
45. Scholz A, Vogel W (2000) Tetrodotoxin-resistant action potentials in dorsal root ganglion neurons are blocked by local anesthetics. Pain 89:47-52
46. Sinnott CJ, Cogswell LP, Johnson A, Strichartz GR (2003) On the mechanism by which epinephrine potentiates lidocaine's peripheral nerve block. Anesthesiology 98:181-188
47. Stevens MF, Hoppe M, Holthusen H, Lipfert P (2004) Tetrodotoxininduced conduction blockade is prolonged by hyaluronic acid with and without bupivacaine. Acta Anaesthesiol Scand 48:128-134
48. Strichartz G, Rando T, Hall S, Gitschier J, Hall L, Magnani B, Bay CH (1986) On the mechanism by which saxitoxin binds to and blocks sodium channels. Ann NY Acad Sci 479:96-112
49. Wagner HH, Ulbricht W (1976) Saxitoxin and procaine act independently on separate sites of the sodium channel. Pflugers Arch 364:65-70
50. Wong K, Strichartz GR, Raymond SA (1993) On the mechanisms of potentiation of local anesthetics by bicarbonate buffer: drug structure-activity studies on isolated peripheral nerve. Anesth Analg 76:131-143